Aurobindo Pharma launches Adquey in US dermatology market
Acrotech Biopharma, a subsidiary of Aurobindo Pharma, has launched Adquey (difamilast 1%) in the US for mild-to-moderate atopic dermatitis. The non-steroidal topical ointment, licensed from Japan's Otsuka Pharmaceutical, is approved for adults…









































Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.